ClinicalTrials.gg
Status unknownNCT04984460Updated Jul 30, 2021

Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals

An observational study in Vaginitis, sponsored by Affiliated Hospital of Nantong University. Status unknown at 10 sites in China. Open to female participants aged 14 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-07-30.

Sponsored by Affiliated Hospital of Nantong University · Observational

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,000
Ages
14 Years to 70 Years
Sex
Female
01

Study summary

The purpose of this study is to compare the results of different detection methods for non-gestational fungal vaginitis (VVC), and to evaluate the significance of different fungal states in the results for diagnosis and treatment.

Read the detailed description

The study was divided into two phases: in the first phase, the vaginal secretions of 1000 enrolled patients with fungal vaginitis were detected with 3/4 different methods, and the sensitivity, specificity and consistency of these methods were compared; In the second stage, 1000 patients from the first stage were selected to meet the follow-up stage and divided into two groups. The test of Follow-up fungal culture and fluorescence morphological detection of liquid-based thin-layer film-making fungi were performed periodically. At last, the applicant will analyze the data, write the paper and publish the article.

02

Conditions studied

  • Vaginitis

Browse trials for

Keywords

  • Fluorescence morphological
  • liquid-based thin-layer film-making
  • Fungal vaginitis
03

In context

Vaginitis

98 studies on the registry are indexed under Vaginitis; 12 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 140 across 22 observational studies indexed under Vaginitis.

Browse Vaginitis studies →

Lead sponsor

Affiliated Hospital of Nantong University is the lead sponsor of 97 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Female patients with suspected fungal vaginitis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. Samples from outpatient or inpatient clinics to be tested for fungal vaginitis.
    1. A sample of one or more of the following characteristics. 2.1 Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased.

2.2 Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd.

    1. The samples are vaginal secretions from the female body. Each sample should be the amount on one swab.
    1. The sample is not in menstrual period.
    1. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

Exclusion criteria

Exclusion Criteria:

    1. Cases with incomplete specimen collection;
    1. Mixed vaginitis cases;
    1. Abscission cases with incomplete follow-up.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
10 Months
Patient registry
Yes

Groups and cohorts

  • life-style counseling

    A sample of one or more of the following characteristics. Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased. Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd.

    Diagnostic Test: Fluorescence morphological detection of liquid-based thin-layer film-making fungi

Interventions

  • Diagnostic testFluorescence morphological detection of liquid-based thin-layer film-making fungi

    Samples from outpatient or inpatient clinics to be tested for fungal vaginitis. A sample of one or more of the following characteristics. Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased. Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd. Samples are human vaginal secretions. Each sample should be the amount on one swab. The sample is not in menstrual period. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

06

What researchers measure

Primary outcomes

  1. Comparing the positive detection rate of 3/4 different detection methods in the first phase.

    The positive coincidence rate (sensitivity), negative coincidence rate (specificity) and total coincidence rate (consistency) was compared, according to the P\<0.05 was used to determine whether it was statistically significant.

    Time frame: From Aug. 1st to Dec. 31st, 2021

  2. Calculating the proportion of the number of fungi in three different states in the map results of three/four detection methods.

    Counting The number and proportion of mycelia, spores and blastospores, especially the percentage of cases of single spore (+) in all cases of fungus (+).

    Time frame: From Aug. 1st, 2021 to Jan. 31st, 2022

  3. Counting the positive numbers of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests and fungal culture in the Stage 2_follow-up stage.

    the positive coincidence rate (sensitivity), negative coincidence rate (specificity) of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests

    Time frame: From Mar. 1, 2022 to Dec. 31st, 2022

07

Study locations

10 sites
  • The First Affiliated Hospital of Ustc
    Hefei, Anhui 230031, China
  • Zhongshan City People's Hospital
    Zhongshan, Guangdong, China
  • The Second Affiliated Hospital of Nantong University
    Nantong, Jiangsu 226001, China
  • Affiliated Hospital of Nantong University
    Nantong, Jiangsu 226006, China
  • Affiliated Nantong Hospital Of Shanghai University
    Nantong, Jiangsu, China
  • Nantong Maternal and Child Health Hospital
    Nantong, Jiangsu, China
  • Children's Hospital of Fudan University Qidong Branch
    Qidong, Jiangsu, China
  • Jiujiang Maternal and Child Health Hospital
    Jiujiang, Jiangxi, China
  • Jiangxi Maternal and Child Health Hospital
    Nanchang, Jiangxi 330006, China
  • Changning District Maternal and Child Health Care Hospital
    Shanghai, Shanghai 200051, China
08

References and documents

Individual participant data

Plan to share: No — Not planning sharing at present.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04984460
Lead sponsor
Affiliated Hospital of Nantong University
Responsible party
Yuquan Zhang (Director of Obstetrics and Gynaecology, Affiliated Hospital of Nantong University) — Principal investigator
First posted
Jul 30, 2021
Start date
Jul 9, 2021
Primary completion
Dec 31, 2022 (estimated)
Completion
Apr 1, 2023 (estimated)
Last update
Jul 30, 2021

Study contacts

Yuquan Zhang, Doctor
principal investigator · Affiliated Hospital of Nantong University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion